Global Medical REIT (NYSE:XRN) Upgraded to Hold at Wall Street Zen

Key Points

• Global Medical REIT was upgraded by Wall Street Zen from "sell" to "hold" and by Weiss Ratings from "sell (d+)" to "hold (c-)," while the MarketBeat consensus is a Moderate Buy with a consensus price target of $40.50.
• The stock opened at $33.19, trading in a one‑year range of $29.05–$43.05, with a market capitalization of $439.1 million, a negative P/E (-36.88) and a debt‑to‑equity ratio of 1.62.
• Institutional investors own 57.52% of the shares, with recent position increases and new stakes from firms including Invesco, Mackenzie Financial, XTX Topco, Tudor Investment and Clifford Capital Partners.

Global Medical REIT (NYSE:XRN - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Saturday.

Separately, Weiss Ratings upgraded Global Medical REIT from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Global Medical REIT presently has a consensus rating of "Moderate Buy" and a consensus price target of $40.50.

Global Medical REIT Stock Down 0.2%

Shares of NYSE:XRN opened at $33.19 on Friday. Global Medical REIT has a 1 year low of $29.05 and a 1 year high of $43.05. The company has a debt-to-equity ratio of 1.62, a current ratio of 0.61 and a quick ratio of 0.61. The business's 50-day moving average is $35.46 and its 200-day moving average is $34.16. The company has a market capitalization of $439.10 million, a price-to-earnings ratio of -36.88 and a beta of 1.16.

Hedge Funds Weigh In On Global Medical REIT

A number of institutional investors have recently modified their holdings of XRN. Invesco Ltd. grew its position in Global Medical REIT by 4.2% in the 4th quarter. Invesco Ltd. now owns 310,432 shares of the company's stock valued at $10,474,000 after purchasing an additional 12,471 shares during the period. Mackenzie Financial Corp acquired a new position in Global Medical REIT during the fourth quarter worth $563,000. XTX Topco Ltd bought a new position in shares of Global Medical REIT in the fourth quarter valued at $515,000. Tudor Investment Corp ET AL bought a new position in shares of Global Medical REIT in the fourth quarter valued at $930,000. Finally, Clifford Capital Partners LLC grew its holdings in shares of Global Medical REIT by 31.3% during the fourth quarter. Clifford Capital Partners LLC now owns 14,694 shares of the company's stock valued at $496,000 after buying an additional 3,504 shares during the last quarter. 57.52% of the stock is owned by institutional investors and hedge funds.

Global Medical REIT Company Profile

Global Medical REIT NYSE: GMRE is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.